An Unbiased View of Temazepam
An Unbiased View of Temazepam
Blog Article
Coadministration with CYP3A4 substrates, notably People having a slim therapeutic index, can lead to diminished concentrations and lack of efficacy. If not able to stay clear of coadministration, monitor CYP3A4 substrate amounts and change dose as desired.
bremelanotide will reduce the extent or impact of triazolam by Other (see comment). Steer clear of or Use Alternate Drug. Bremelanotide may possibly gradual gastric emptying and potentially reduces the rate and extent of absorption of concomitantly administered oral medicines.
Repotrectinib is often a CYP3A4 inducer. Prevent coadministration with CYP3A substrates where small concentration adjustments can cause diminished efficacy, unless normally suggested their prescribing facts.
Check Closely (1)pirtobrutinib will increase the level or effect of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
If you're taking some other medication that will make you sleepy. There are numerous medicines which will try this. Question your medical professional or pharmacist if You aren't positive. This is simply not a summary of all medication or health problems that communicate with this drug.
butalbital will decrease the extent or influence of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an Triazolam eye on.
istradefylline will increase the stage or effect of triazolam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
If estazolam is provided concomitantly with other medicines acting over the central nervous program, mindful consideration need to be offered towards the pharmacology of all brokers.
diltiazem will raise the level or result of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
Pregnancy Exposure Registry There's a pregnancy registry that monitors pregnancy results in Girls exposed to psychiatric medications, such as estazolam, during pregnancy.
Contemplate minimizing the dose with the delicate CYP3A4 substrate and watch for indications of toxicities of the coadministered delicate CYP3A substrate.
Contraindicated. Nirmatrelvir/ritonavir is contraindicated with medicine that happen to be remarkably depending on CYP3A for clearance and for which elevated concentrations are linked to critical and/or daily life-threatening reactions.
butabarbital will lower the extent or result of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
Stiripentol can be a CYP3A4 inhibitor and inducer. Keep an eye on CYP3A4 substrates coadministered with stiripentol for improved or decreased results. CYP3A4 substrates could need dosage adjustment.